Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 193, Issue 9, Pages 1023-1031
Publisher
American Thoracic Society
Online
2015-12-14
DOI
10.1164/rccm.201508-1573oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
- (2014) A Linton et al. BRITISH JOURNAL OF CANCER
- Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
- (2014) Francine Baumann et al. CARCINOGENESIS
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Immunomodulation in cancer
- (2014) Joost PJJ Hegmans et al. CURRENT OPINION IN PHARMACOLOGY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4
- (2014) James Badger Wing et al. IMMUNITY
- Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
- (2014) Pietro Bovolato et al. Journal of Thoracic Oncology
- Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
- (2014) Ahmad A. Tarhini et al. PLoS One
- Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
- (2013) Luana Calabrò et al. LANCET ONCOLOGY
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New Roads Open Up for Implementing Immunotherapy in Mesothelioma
- (2012) R. Cornelissen et al. Clinical & Developmental Immunology
- Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
- (2011) Christina S. Chu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma
- (2011) A. Nakas et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients
- (2011) C. Alfaro et al. JOURNAL OF IMMUNOLOGY
- Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
- (2011) Giovanni L. Ceresoli et al. LUNG CANCER
- Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
- (2011) P.A. Zucali et al. LUNG CANCER
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Immunotherapy response evaluation with 18F-FDG-PET in patients with advanced stage renal cell carcinoma
- (2011) Rozemarie Gilles et al. WORLD JOURNAL OF UROLOGY
- Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
- (2010) Joost P. Hegmans et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions
- (2010) Daniel H Sterman et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started